Vaccines
9 May 2014
Pfizer Announces Positive Phase 2 Study Results for Investigational Meningococcal B Vaccine30 April 2014
New Experimental Vaccine Produces Immune Response Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)29 April 2014
Transgene Announces Option for TG4010 Not Exercised28 April 2014
NanoBio’s Intranasal Vaccine Demonstrates Robust Protection Against Herpes Simplex-2 Infection28 April 2014
The Worlds First, Large-Scale Dengue Vaccine Efficacy Study Successfully Achieved Its Primary Clinical Endpoint24 April 2014
Promising results in phase 1 trial lead immatics to continue work on vaccine (IMA950) for glioblastoma22 April 2014
World Malaria Day 2014: New Vaccine Candidates Against Malaria Enter Clinical Development16 April 2014
Emergent BioSolutions Successfully Completes Pivotal Clinical Study to Support Expanded Indication for BioThrax15 April 2014
Dynavax Initiates Phase 3 Study of HEPLISAV-B(TM)14 April 2014
Cytos Biotechnology Ltd announces negative topline results of clinical trial with CYT00311 April 2014
New Clinical Data Demonstrate Strong Synergy between Cancer Vaccine ISA101 and Chemotherapy7 April 2014
Novartis meningitis B vaccine Bexsero® receives FDA Breakthrough Therapy designation in the USNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports